A systematic review and meta-analysis of local salvage therapies after radiotherapy for prostate cancer (MASTER)
Context Management of locally recurrent prostate cancer after definitive radiotherapy
remains controversial due to the perceived high rates of severe genitourinary (GU) and …
remains controversial due to the perceived high rates of severe genitourinary (GU) and …
The diagnosis and treatment of prostate cancer: a review
Importance Prostate cancer is the most common cancer diagnosis made in men with more
than 160 000 new cases each year in the United States. Although it often has an indolent …
than 160 000 new cases each year in the United States. Although it often has an indolent …
Clinically localized prostate cancer: AUA/ASTRO guideline, part I: introduction, risk assessment, staging, and risk-based management
JA Eastham, GB Auffenberg, DA Barocas… - The Journal of …, 2022 - auajournals.org
Purpose: The summary presented herein represents Part I of the three-part series dedicated
to Clinically Localized Prostate Cancer: AUA/ASTRO Guideline, discussing risk assessment …
to Clinically Localized Prostate Cancer: AUA/ASTRO Guideline, discussing risk assessment …
Androgen deprivation therapy use and duration with definitive radiotherapy for localised prostate cancer: an individual patient data meta-analysis
Background Randomised trials have investigated various androgen deprivation therapy
(ADT) intensification strategies in men receiving radiotherapy for the treatment of prostate …
(ADT) intensification strategies in men receiving radiotherapy for the treatment of prostate …
Local failure events in prostate cancer treated with radiotherapy: a pooled analysis of 18 randomized trials from the meta-analysis of randomized trials in cancer of the …
Context The prognostic importance of local failure after definitive radiotherapy (RT) in
National Comprehensive Cancer Network intermediate-and high-risk prostate cancer (PCa) …
National Comprehensive Cancer Network intermediate-and high-risk prostate cancer (PCa) …
Clinically localized prostate cancer: AUA/ASTRO guideline. Part III: principles of radiation and future directions
JA Eastham, GB Auffenberg, DA Barocas… - Journal of …, 2022 - journals.lww.com
Purpose: The summary presented herein represents Part III of the three-part series
dedicated to Clinically Localized Prostate Cancer: AUA/ASTRO Guideline, discussing …
dedicated to Clinically Localized Prostate Cancer: AUA/ASTRO Guideline, discussing …
Prostate radiotherapy with adjuvant androgen deprivation therapy (ADT) improves metastasis-free survival compared to neoadjuvant ADT: an individual patient meta …
PURPOSE There remains a lack of clarity regarding the influence of sequencing of
androgen deprivation therapy (ADT) and radiotherapy (RT) on outcomes in prostate cancer …
androgen deprivation therapy (ADT) and radiotherapy (RT) on outcomes in prostate cancer …
Evolution of androgen deprivation therapy (ADT) and its new emerging modalities in prostate cancer: an update for practicing urologists, clinicians and medical …
E Choi, J Buie, J Camacho, P Sharma… - Research and reports …, 2022 - Taylor & Francis
Androgen deprivation therapy (ADT) has been the main management strategy for prostate
cancer for more than eight decades, nowadays achieved commonly by administration of …
cancer for more than eight decades, nowadays achieved commonly by administration of …
First statement on preparation for the COVID-19 pandemic in large German Speaking University-based radiation oncology departments
SE Combs, C Belka, M Niyazi, S Corradini… - Radiation …, 2020 - Springer
The COVID-19 pandemic is challenging modern radiation oncology. At University Hospitals,
we have a mandate to offer high-end treatments to all cancer patients. However, in times of …
we have a mandate to offer high-end treatments to all cancer patients. However, in times of …
Dose-escalated radiotherapy alone or in combination with short-term androgen deprivation for intermediate-risk prostate cancer: results of a phase III multi-institutional …
DJ Krauss, T Karrison, AA Martinez… - Journal of Clinical …, 2023 - ascopubs.org
PURPOSE It remains unknown whether or not short-term androgen deprivation (STAD)
improves survival among men with intermediate-risk prostate cancer (IRPC) treated with …
improves survival among men with intermediate-risk prostate cancer (IRPC) treated with …